<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04756349</url>
  </required_header>
  <id_info>
    <org_study_id>UFPara</org_study_id>
    <nct_id>NCT04756349</nct_id>
  </id_info>
  <brief_title>Clinical Performance of Adhesive Systems Containing HEMA and 10-MDP in Non Carious Cervical Lesions</brief_title>
  <official_title>Clinical Performance of Adhesive Systems Containing HEMA and 10-MDP in Non Carious Cervical Lesions - A Two Years Randomized Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Para</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal do Para</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this randomized, double-blind clinical trial is to evaluate the clinical&#xD;
      performance of non-carious cervicals adhesive restorations using three self-etching adhesives&#xD;
      containing HEMA and 10-MDP monomers. Sixty teeth (n = 20 for each group) will be randomized&#xD;
      into 03 groups: Clearfil SE (contains MDP and HEMA), Optibond All-inOne (contains HEMA) and&#xD;
      Prime and Bond Universal (contains neither monomer) dispatch). Restorations will be performed&#xD;
      by a single operator, and no mechanical retention will be performed under the cavity. After&#xD;
      6, 12 and 24 months, the restorations will be evaluated by two calibrated examiners, using&#xD;
      modified USPHS criteria for retention (kappa = 1.00) and adaptation / marginal color (kappa =&#xD;
      0.81), and the results will be analysed by Fisher and Kruskal-Wallis, respectively. An&#xD;
      intragroup analysis will be performed using the Cochran test (for retention) and Wilcoxon&#xD;
      (for marginal adaptation / staining).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 12, 2020</start_date>
  <completion_date type="Anticipated">February 12, 2022</completion_date>
  <primary_completion_date type="Actual">February 12, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retention rate of restoration</measure>
    <time_frame>01 year</time_frame>
    <description>The retention rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):&#xD;
Alpha = retained. Charlie = mobility or loss.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention rate of restoration</measure>
    <time_frame>02 years</time_frame>
    <description>The retention rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):&#xD;
Alpha = retained. Charlie = mobility or loss.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Marginal staining rate of restoration</measure>
    <time_frame>01 year</time_frame>
    <description>The marginal staining rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):&#xD;
Alpha = no staining. Bravo = superficial staining (localized or generalized). Charlie = deep staining (localized or generalized).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marginal staining rate of restoration</measure>
    <time_frame>02 years</time_frame>
    <description>The marginal staining rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):&#xD;
Alpha = no staining. Bravo = superficial staining (localized or generalized). Charlie = deep staining (localized or generalized).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marginal Adaptation rate of restoration</measure>
    <time_frame>01 year</time_frame>
    <description>The marginal adaptation rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):&#xD;
Alpha = no visible evidence of a crack along the edge, the explorer will not penetrate.&#xD;
Bravo = visible evidence of a crack along the margin, dentin unexposed, clinically acceptable.&#xD;
Charlie = explorer penetrates the crack, dentin exposed, clinically unacceptable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marginal Adaptation rate of restoration</measure>
    <time_frame>02 years</time_frame>
    <description>The marginal adaptation rate will be assessed following the USPHS (United States Public Health) guidelines with the following classifications (acronyms):&#xD;
Alpha = no visible evidence of a crack along the edge, the explorer will not penetrate.&#xD;
Bravo = visible evidence of a crack along the margin, dentin unexposed, clinically acceptable.&#xD;
Charlie = explorer penetrates the crack, dentin exposed, clinically unacceptable.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Postoperative sensitivity rate of restoration</measure>
    <time_frame>01 year</time_frame>
    <description>present or absent</description>
  </other_outcome>
  <other_outcome>
    <measure>Postoperative sensitivity rate of restoration</measure>
    <time_frame>02 years</time_frame>
    <description>present or absent</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary caries rate of restoration</measure>
    <time_frame>01 year</time_frame>
    <description>present or absent</description>
  </other_outcome>
  <other_outcome>
    <measure>Secondary caries rate of restoration</measure>
    <time_frame>02 years</time_frame>
    <description>present or absent</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Non Carious Cervical Lesion</condition>
  <arm_group>
    <arm_group_label>Clearfil SE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Optibond All-in-One</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Prime &amp; Bond Universal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>composite resin restoration</intervention_name>
    <description>All patients will receive adhesive composite resin restorations. There will be 3 groups (different adhesives): Clearfil SE, Optibond All-in-One and Prime &amp; Bond Universal.</description>
    <arm_group_label>Clearfil SE</arm_group_label>
    <arm_group_label>Optibond All-in-One</arm_group_label>
    <arm_group_label>Prime &amp; Bond Universal</arm_group_label>
    <other_name>composite resin restorations with Clearfil SE adhesive</other_name>
    <other_name>composite resin restorations with Optibond All-in-One adhesive</other_name>
    <other_name>composite resin restorations with Prime &amp; Bond Universal adhesive</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Good oral hygiene&#xD;
&#xD;
          -  Absence of periodontal disease&#xD;
&#xD;
          -  Presence of at least 02 non-carious cervical lesions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of non-carious cervical lesion in non-vital teeth&#xD;
&#xD;
          -  Occlusal instability&#xD;
&#xD;
          -  Presence of orthodontic appliance&#xD;
&#xD;
          -  Presence of removable partial dental prosthesis&#xD;
&#xD;
          -  High risk of caries (presence of three or more active caries lesions)&#xD;
&#xD;
          -  Xerostomia&#xD;
&#xD;
          -  Bruxism&#xD;
&#xD;
          -  Patients allergic to base materials monomers&#xD;
&#xD;
          -  Patients who do not accept the project conditions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Para's Federal University</name>
      <address>
        <city>Belém</city>
        <state>Pará</state>
        <zip>66075-110</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 5, 2021</study_first_submitted>
  <study_first_submitted_qc>February 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2021</study_first_posted>
  <last_update_submitted>March 9, 2021</last_update_submitted>
  <last_update_submitted_qc>March 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal do Para</investigator_affiliation>
    <investigator_full_name>Cecy Martins Silva</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <keyword>adhesives</keyword>
  <keyword>dental bonding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

